← SynDRA
PD-156707
SynDRA canonical compound SYN0000337 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EDNRA | EDNRB |
|---|
| Mechanism of action | endothelin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- EDNRA ANTAGONIST
- endothelin receptor antagonist
Cross-references
Synonyms
- PD156707
- CHEMBL25438
- GTPL999
- DTXSID80635455
- HMS3263B04
- Tox21_501201
- CCG-222505
- NCGC00261886-01
- LS-34623
- P-305
- PD-156707, >
- Sodium (Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate.
- Sodium (2Z)-2-(2H-1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate
- sodium (Z)-2-(1,3-benzodioxol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[(3,4,5-trimethoxyphenyl)methyl]but-2-enoate
- CI 1020
- RefChem:918596
- DTXCID30382942
- PD 156707
- CI1020-d9
- CI1020
- PWIPORDFWDZCJG-UHFFFAOYSA-N
- orb1704614
- SCHEMBL4178950
- SCHEMBL30708648
- WDC60245
- BDBM50034267
- EX-A14422
- AKOS024457348
- FC20425
- MS-33265
- DB-090379
- HY-103459
- CS-0027936
- T22663
Look up PD-156707 in the interactive SynDRA portal →